Indoco Remedies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
INDOCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indoco Remedies has informed the stock exchanges that its trading window will be closed from Thursday, January 1, 2026, until 48 hours after the company declares its Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2025. During this period, all designated persons of the company, including their immediate relatives, are barred from buying or selling the company's equity shares. This is a standard compliance measure under SEBI's Insider Trading Regulations, 2015. The date of the board meeting to approve the Q3 FY26 results has not yet been announced and will be communicated later.
This is a routine regulatory compliance filing and not a material business event. The closure typically signals that quarterly results are approaching, which could be a catalyst for the stock once the window reopens after results are announced.